市场调查报告书
商品编码
1447713
远距患者监护市场:按产品、应用和最终用户划分——到 2031 年的全球预测Remote Patient Monitoring Market by Product, Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031 |
预计到 2031 年,全球远距病患监护市场将达到 1,168.4 亿美元,2024 年至 2031 年的复合年增长率为 13.7%。
该报告基于全面的一手和二手研究以及对市场情景的详细分析,提供了该行业的关键驱动因素、限制因素、挑战和机会。 该市场的推动因素包括老年人口不断增长、慢性病患病率上升、医疗保健专业人员短缺、人们越来越认识到RPM 的好处(例如便利性和改善患者治疗效果)以及降低医疗成本的需求不断增长。驱动因素包括政府的有利措施促进远距患者监护。
此外,远距医疗和远距患者监护方面的技术进步、新兴国家患者数量的增加、可穿戴设备的日益普及、感测器技术的进步以及人工智慧和RPM 的整合正在推动该市场的显着增长。我们提供机会。 然而,对数据准确性和可靠性的担忧、限制远端患者监测技术使用的障碍(例如存取限制)以及患者技术素养较低正在限制市场成长。 此外,对资料安全和隐私的担忧,以及由于需要额外的人员来管理 RPM 系统而增加的管理成本,都对市场构成了挑战。
以产品来看,预计到2024年,监护设备领域将占据远距病患监护市场的最大份额。 此细分市场的重要份额是由于各种慢性病的盛行率不断上升、老年人口不断增加、有利的监管环境、感测器技术的技术进步、个人化医疗保健的需求不断增长、监测设备的人为增长。这是由于以下因素智能与机器学习的融合。
从应用来看,糖尿病领域预计将在 2024 年占据远端患者监测市场的最大份额。 传统上,糖尿病主要被认为是一种遗传性疾病,但其迅速流行使其被认为是一种与生活方式相关的疾病。 这个细分市场的很大一部分是由于远距医疗在糖尿病管理中的使用、糖尿病盛行率的增加以及监测糖尿病患者的需求增加等因素造成的。
从最终用户来看,家庭医疗保健领域预计将在 2024 年占据远距患者监护市场的最大份额。 该细分市场的巨大市场份额是由家庭护理环境的日益转变、老年人慢性病发病率的增加、医疗专业人员的短缺以及消费者对使用RPM工具监测慢性病的意识不断增强等推动的。
对全球远距病患监护市场区域状况的详细分析提供了五个关键区域的详细定性和定量见解。 到2024年,预计北美将占据全球远距病患监护市场的最大份额,其次是欧洲、亚太地区、拉丁美洲以及中东和非洲。 亚太地区预计将成为全球远距患者监护市场成长最快的地区。 这一增长主要是由医疗保健支出增加、老年人口不断增长、慢性病患病率上升、消费者意识提高、个人可支配收入增加以及更大的目标人群推动的,从而支持了市场成长。
Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User-Global Forecast to 2031
The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.
Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.
Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.
Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.
Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.
An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.
The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).
Remote Patient Monitoring Market Assessment-by Product
Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.
Remote Patient Monitoring Market Assessment-by Application
Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.
Remote Patient Monitoring Market Assessment-by End User
Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations
Remote Patient Monitoring Market Assessment-by Geography